ICAM1 and inflammatory bowel disease: Increased expression of ICAM-1 and VCAM-1 (Fig. 1), which has been shown to resolve at the gene expression level following anti-TNF treatment (41), may enable entry of these cells into the intestinal mucosa in IBD.